Long chain fatty acids in health and nutrition

Journal of Food Lipids

Volumn 3, Issue 4, 1996, Pages 233-249

  Newton, Ian S ^a  

^a HOFFMANN LA ROCHE INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0141779768     PISSN: 10657258     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1745-4522.1996.tb00071.x     Document Type: Article

References (67)

1. ABBEY, M., CLIFTON, P., KESTIN, M., BELLING, B. and NESTEL, P. 1990. Effect of fish oil on lipoproteins, lecithin:cholesterol acyltransferase, and lipid transfer protein activity in humans. Arteriosclerosis 10, 85-94.
2. ADAMS, P.B., LAWSON, S., SANIGORSKI, A. and SINCLAIR, A.J. 1996. Arachidonic acid to eicosapentanenoic acid ratio in blood correlates positively with clinical symptoms of depression. Lipids 31, S157-S161.
3. Agricultural Research Service, U.S. Department of Agriculture. Handbook Number 8. Washington, DC, 1976.
4. ASCHERIO, A. 1995. Dietary intake of marine n-3 fatty acids, fish intake and the risk of coronary disease among men. N. Engl. J. Med. 332, 977-982.
5. BILLMAN, G.E., HALLAW, H. and LEAF, A. 1994. Prevention of ischemia-induced ventricular fibrillation by omega-3 fatty acids. Proc. Natl. Acad. Sci. USA. 91, 4427-4430.
6. BJERVE, K.S., MOSTAD, L.A. and THORENSEN, L. 1987. Alpha-linolenic acid deficiency in patients on long-term gastric-tube feeding: Estimation of linolenic acid and long-chain unsaturated n-3 fatty acid requirement in man. Am. J. Clin. Nutr. 45, 66-77.
7. BUDOWSKI, P. 1988. N-3 fatty acids in health and disease. World Rev. Nutr. Diet. 57, 214-274.
8. BURR, M.L. 1989. Effects of changes in fat, fish and fibre intakes on death and myocardial reinfarction: Diet and Reinfarction Trial (DART). Lancet, ii, 757-761.
9. BURR, M.L. 1992. Fish food, fish oil and cardiovascular disease. Clin. Exper. Hypertension A14, 181-192.
10. CARLSON, S. 1995. The role of PUFA in infant nutrition. INFORM. 6, 940-946.
11. CHAN, J.K., MCDONALD, B.E., GERRARD, J.M., BRUCE, V.M., WEAVER, B.J. and HOLUB, B.J. 1993. Effect of dietary alpha-linolenic acid and its ratio to linoleic acid on platelet and plasma fatty acids and thrombogenisis. Lipids 28, 811-817.
12. CHRISTENSEN, J.H., EJLERSEN, E. and JESSEN, T. 1995. n-3 Fatty acids and ventricular extrasystoles in patients with ventricular tachyarrhythmias. Nutr. Res. 15, 1-8.
13. CLANDININ, M.T., CHAPPEL, J.E., HEIM, T., SWYER, P.R. and CHANCE, G.W. 1981. Fatty acid accretion in fetal and neonatal liver: implications for fatty acid requirements. Early Hum. Dev. 5, 1-6.
14. CLANDININ, M.T., CHAPPEL, J.E., LEONG, S., HEIM, T., SWYER, P.R. and CHANCE, G.W. 1980. Intrauterine fatty acid accretion rates in human brain: implications for fatty acid requirements. Early Hum. Dev. 4, 131-138.
15. CONNER, W.E. 1991. Evaluation of publicly available evidence regarding certain nutrient-disease relationships: 7. Omega-3 fatty acids and heart disease. Bethesda, MD: Fed. Am. Soc. Ex. Biol. FDA Contract No. 223-88-2124.
16. CONNOR, W.E., NEURINGER, M. and REISBICK, S. 1992. Essential fatty acids: the importance of n-3 fatty acids in the retina and brain. Nutr. Rev. 50(4), 21-29.
17. DEHMER, G.J., POMPA, J.J., VAN DEN BERG, E.K., EICHORN, E.J., PREWITT, J.B., CAMPBELL, W.B., JENNINGS, L., WILLERSON, J.T. and SCMITZ, J.M. 1988. Reduction in the rate of early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids. N. Engl. J. Med. 319, 733-740.
18. DEPARTMENT OF HEALTH 1991. Dietary Reference Values for Food Energy and Nutrients for the United Kingdom. Committee on Medical Aspects of Food Policy. Report on Health and Social Subjects, 41, HMSO, London.
19. DOLECEK, T.A. 1992. Epidemiological evidence of relationships between dietary PUFA and mortality in multiple risk factor intervention trial (MRFIT), P.S.E.B.M. 200, 177-182.
20. ENDRES, S., DE CATERINA, R., SCHMIDT, E.B. and KRISTENSEN, S.D. 1995. N-3 polyunsaturated fatty acids: update 1995. Eur. J. Clin. Invest. 25, 629-638.
21. ERNST, E. 1990. Plasma fibrinogen-an independent cardiovascular risk factor. J. Intern. Med. 227, 365-372.
22. FEHILY, A.M., BURR, M.L., PHILLIPS, K.M. and DEADMAN, N.M. 1983. The effect of fatty fish on plasma lipid and lipoprotein concentrations. Am. J. Clin. Nutr. 38, 349-351.
23. Food and Nutrition Board, National Research Council, National Academy of Sciences. 1989. Recommended Dietary Allowances, 10th Edition. Washington DC.
24. FORTIN, P.R. 1995. Validation of a Meta-Analysis: The effects of fish oil in rheumatoid arthritis. J. Clin. Epidemiol. 48, 1379-1390.
25. GAPINSKI, J.P., VANRUISWYK, J.V., HEUDEBERT, G.R. and SCHECTMAN, G.S. 1993. Preventing restenosis with fish oils following coronary angioplasty. A meta-analysis. Arch. Intern. Med. 153, 1595-1601.
26. GERSTER, H. 1993. Fish oil (n-3 long-chain PUFAs) and blood pressure. Nutrition 17, 15-24.
27. GERSTER, H. 1995. The use of n-3 PUFA (fish oil) in enteral nutrition. Internat. J. Vit. Nutr. Res. 65, 3-20.
28. HALLAQ, H., SELLMAYER, A., SMITH, T.W. and LEAF, A. 1990. Protective effect of eicosapentaenoic acid on ouabain toxicity in neonatal rat cardiac myocytes. Proc. Natl. Acad. Sci. USA 87, 7834-7838.
29. HALLAQ, H., SMITH, T.H. and LEAF, A. 1992. Modulation of dihydropyridine-sensitive calcium channels in heart cells by fish oil fatty acids. Proc. Natl. Acad. Sci. USA. 89, 1760-1764.
30. HAMAZAKI, T., SAWAZAKI, S., ITOMURA, M., ASAOKA, E.M., NAGAO, Y., NISJIURA, N., YAZAWA, K., KUAMORI, T. and KOBAYASHI, M. 1996. The effect of docasahexaenoic acid on aggression in young adults. J. Clin. Invest. 97, 1129-1134.
31. HARRIS, W.S., ROTHROCK, D.W. and FANNING, A. 1990. Fish oils in hypertriglyeridemia; A dose response study. Am J. Clin. Nutr. 51, 399-406.
32. Health and Welfare Canada 1990. Nutrition Recommendations. Ottawa, Canada: Minister of Supply and Services.
33. HIBBELN, J.R. and SALEM, JR., N. 1995. Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy. Am. J. Clin. Nutr. 62, 1-9.
34. HORNSTRA, G., AL, M.D.M., VAN HOUWELINGEN, A.C. and FOREMAN-VAN DRONGELEN, M.M. 1995. Essential fatty acids in pregnancy and early human development. Eur. J. Obstet. Gynecol. Reprod. Biol. 61, 57-62.
35. HOSTMARK, A.T., BJERKEDAL, T., KIERULF, P., FLATEN, H. and ULSHAGEN, K. 1988. Fish oil and plasma fibrinogen. Br. Med. J. 297, 180-181.
36. INNIS, S.M. 1992. N-3 fatty acid requirements of the newborn. Lipids 27, 879-885.
37. KANG, J.X. and LEAF, A. 1995. Prevention and termination of beta-adrenergic agonist-induced arrhythmias by free polyunsaturated fatty acids in neonatal rat cardiac myocytes. Biochem. Biophys. Res. Commun. 208, 629-636.
38. KINSELLA, J.E., LOKESH, B. and STONE, R.A. 1990. Dietary n-3 polyunsaturated fatty acids and amelioration of cardiovascular disease: possible mechanisms. Am. J. Clin. Nutr. 52, 1-28.
39. KNAPP, H.R. 1989, The antihypertensive effects of fish oil. A controlled study of polyunsaturated fatty acids supplements in essential hypertension. N. Engl. J. Med. 320, 1037-1043.
40. LEAF, A. 1990. Cardiovascular effects of fish oils. Beyond the platelet. Circulation 82, 624-662.
41. LEAF, A. 1995. Omega-3 fatty acids and prevention of ventricular fibrillation. Prosta. Leuko. Essen. Fatty. Acid. 52, 197-198.
42. LEAF, A. and WEBER, P.C. 1987. A new era for science in nutrition. Am. J. Clin. Nutr. 45(suppl), 1048-1053.
43. LEE, R.M.K.W. 1994. Fish oil, essential fatty acids, and hypertension. Can. J. Physiol. Pharmacol. 72, 945-953.
44. LOFGREN, R.P., WILT, T.J., NICHOL, K.L., CRESPIN, L., PLUHAR, R. and ECKFELDT, J. 1993. The effect of fish oil supplements on blood pressure. Am. J. Pub. Health 83, 267-269.
45. LUNGERSHAUSEN, Y.K., ABBEY, M., NESTEL, P.J. and HOWE, P.R.C. 1994. Reduction of blood pressure and plasma triglycerides by omega-3 fatty acids in treated hypertensives. J. Hypertension 12, 1041-1045.
46. MARTINEZ, M. 1992. Tissue levels of polyunsaturated fatty acids during early human development. J. Pediatr. 120, S129-S138.
47. MARTINEZ, M. 1996. Docosahexaenoic acid therapy in DHA deficient patients with disorders of peroxisomal biogenesis. Lipids 31, S145-S152.
48. MILNER, M.R., GALLINO, R.A., LEFFINGWELL, A., PICHARD, A.D., ROSENBERG, J. and LINDSAY, J. High dose omega-3 fatty acid supplementation reduces clinical restenosis after coronary angioplasty. Circulation 988;78(S), 634(abstract).
49. MORI, T.A., VANDONGEN, R., BEILIN, L.J., BURKE, V., MORRIS, J. and RITCHIE, J. 1994. Effects of varying dietary fat, fish, and fish oils on blood lipids in a randomized controlled trial in men at risk of heart disease. Am. J. Clin. Nutr. 59, 1060-1068.
50. MORRIS, M.C., SACKS, F. and ROSNER, B. 1993. Does fish oil lower blood pressure? A meta-analysis of controlled trials. Circulation 88, 523-533.
51. NETTLETON, J.A. 1991. n-3 Fatty acids: Comparison of plant and seafood sources in human nutrition. J. Am. Diet. Assoc. 91, 331-337.
52. NEURINGER, M. and CONNOR, W.E. 1986. N-3 fatty acids in the brain and retina: evidence for their essentiality. Nutr. Rev. 4, 285-294.
53. PUTNAM, J.C., CARLSON, S.E., DEVOE, P.W. and BARNESS, L.A. 1982. The effect of variations in dietary fatty acids on the fatty acid composition of erythrocyte phosphatadylcholine and phosphatidylethanolamine in human infants. Am. J. Clin. Nutr. 36, 106-114.
54. RAPER, N.R., CRONIN, F.J. and EXLER, J. 1992. Omega-3 fatty acid content of the US food supply. J. Am. Coll. Nutr. 11, 304-308.
55. SACKS, F.M., HEBERT, P. and APPEL, L.J. 1994. The effect of fish oil on blood pressure and high-density lipoprotein-cholesterol levels in phase I of the Trials of Hypertension Prevention. J. Hypertension 12 (suppl 7), S23-S31.
56. SALEM, JR., N. and PAWLOSKY, R.J. 1994. Health policy aspects of lipid nutrition and early development. World Rev. Nutr. Diet. Basel, Karger. 75, 46-51.
57. SALEM, JR., N. and WARD, G.R. 1993. Are n-3 fatty acids essential nutrients for mammals? World Rev. Nutr. Diet. 72, 128-147.
58. SANDERS, T.A.B., HINDS, A. and PEREIRA, C.C. 1989. Influence of n-3 fatty acids on blood lipids in normal subjects. J. Int. Med. 225:suppl 1, 99-104.
59. SCHMIDT, E.B. and DYERBERG, J. 1994. Omega-3 fatty acids. Current status in cardiovascular medicine. Drugs 47, 405-424.
60. SCHMIDT, E.B., KRISTENSEN, S.D., DE CATERINA, R. and ILLINGWORTH, D.R. 1993. The effects of N-3 fatty acids on plasma lipids and lipoproteins and other cardiovascular risk factors in patients with hyperlipidemia. Atherosclerosis 103, 107-121.
61. SCHMIDT, E.B., NIELSEN, L.K., PEDERSON, J.O., KORNERUP, H.J. and DYERBERG, J. 1990. The effect of n-3 polyunsaturated fatty acids on lipids, platelet function, coagulation, fibrinolysis and monocyte chemotaxis in patients with hypertension. Clin. Chim. Acta 189, 25-32.
62. SELLMAYER, A., WITZGALL, H., LORENZ, R. and WEBER, P.C. 1995. Reduction of ventricular ectopic beats by dietary fish oil in humans. Abstracts of the annual scientific meeting of the European Society of Clinical Investigation, April 2-5, Cambridge, UK.
63. SIMOPOULOS, A.P. 1991. Omega-3 fatty acids in health and disease and in growth and development. Am. J. Clin. Nutr. 54, 438-463.
64. SISCOVICK, D.S., RAGHUNATHAN, T.E., KING, I., WEINMANN, S. and WIEKLUND, K.G. 1995. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. J. Am. Med. Assoc. 274, 1363-1367.
65. SLACK, J.D., PINKERTON, C.A., VAN TASSEL, J., ORR, C.M., SCOTT, M., ALLEN, B. and NASSER, W.K. 1987. Can oral fish oil supplement minimize restenosis after percutaneous transluminal coronary angioplasty? J. Am. Coll. Cardiol. 9(S), 64(abstract).
66. WEBER, P.C. and LEAF, A. 1991. Cardiovascular effects of n-3 fatty acids. World Rev. Nutr. Diet. 66, 218-232.
67. + channels of neonatal rat ventricular myocytes. Proc. Natl. Acad. Sci. USA. 92, 11000-11004.